Document is current

Any future updates will be listed below

Integrated QSAR, docking, pharmacokinetics, and molecular dynamics approaches for designing IRAK4 inhibitors against MYD88^L265P-driven diffuse large B-cell lymphoma

Crossref DOI link: https://doi.org/10.1007/s44371-025-00391-w

Published Online: 2025-12-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark